Literature DB >> 17948347

Trastuzumab--mechanism of action and use.

Olivier Mir, Paul Berveiller, Gérard Pons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948347

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation.

Authors:  Chiu-Ping Liu; Tsung-I Tsai; Ting Cheng; Vidya S Shivatare; Chung-Yi Wu; Chung-Yi Wu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats.

Authors:  Jonathan J Hubbard; Elizabeth M Laurenzana; D Keith Williams; W Brooks Gentry; S Michael Owens
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

3.  Mechanism of cooperative N-glycan processing by the multi-modular endoglycosidase EndoE.

Authors:  Mikel García-Alija; Jonathan J Du; Izaskun Ordóñez; Asier Diz-Vallenilla; Alicia Moraleda-Montoya; Nazneen Sultana; Chau G Huynh; Chao Li; Thomas Connor Donahue; Lai-Xi Wang; Beatriz Trastoy; Eric J Sundberg; Marcelo E Guerin
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 17.694

4.  Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis.

Authors:  Johannes Laengle; Julijan Kabiljo; Leah Hunter; Jakob Homola; Sophie Prodinger; Gerda Egger; Michael Bergmann
Journal:  J Immunother Cancer       Date:  2020-01-02       Impact factor: 13.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.